CGNNT Issues Quality Commitment, Strengthening Safety Defenses with Nuclear Technology
On March 15th, coinciding with International Consumer Rights Day, China General Nuclear Power Techno...
AHTE 2026 Launches Series of Events to Build a Multi-Industry Smart Assembly Ecosystem
With the advancement of manufacturing transformation and upgrading, the demand for high-precision an...
Vetter Invests in Building an Injectable Drug Production Base in Saarland, Germany
Vetter, a pharmaceutical service provider specializing in injectable drug manufacturing, recently an...
Hanmi Pharm Signs Exclusive Distribution Agreement with Mexico's Sanfer for Diabetes Drugs
South Korean pharmaceutical company Hanmi Pharm recently entered into an exclusive distribution agre...
FDA Approves New Indication for J&J's Darzalex Faspro in Multiple Myeloma Treatment
The U.S. Food and Drug Administration (FDA) recently approved a new indication for the Darzalex Fasp...
FDA Grants Breakthrough Therapy Designation to Lifileucel for Cutaneous Lupus Erythematosus Treatment
The U.S. Food and Drug Administration (FDA) has officially granted Breakthrough Therapy Designation ...
Boehringer Ingelheim Announces Phase II Trial Results for Innovative Drug Apecotrep
German family-owned pharmaceutical company Boehringer Ingelheim today announced the results of the P...
Cellares Secures $257 Million Series D Funding to Advance Cell Therapy Platform Development
San Francisco-based Cellares, which describes itself as the first Integrated Development and Manufac...
Gilead Sciences Drug Receives Top NCCN Guideline Recommendation for Specific Metastatic Breast Cancer Treatment
The American biotechnology company Gilead Sciences announced today that its drug Trodelvy (sacituzum...
Important Progress Made in Breast Cancer Single-Cell Atlas Research
Breast cancer is one of the most common malignant tumors in women and a leading cause of cancer-rela...